SOPHiA GENETICS S.A. (SOPH) Stock Analysis & Investment Frameworks
SOPHiA GENETICS S.A. (SOPH) stock analysis on Invetso. Review SOPHiA GENETICS S.A.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
SOPHiA GENETICS S.A. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Healthcare Information Services
- Country: CH
SOPHiA GENETICS S.A. Key Financial Metrics
- Market Cap: $625.69M
- Revenue: $77.27M
- ROE: -136.71%
- ROIC: -48.83%
- Dividend Yield: N/A
About SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. operates as a specialized company within the healthcare technology sector. The firm provides the SOPHiA DDM platform, a cloud-native Software-as-a-Service (SaaS) solution engineered to analyze diverse multimodal datasets and various diagnostic inputs, thereby extracting valuable insights. This platform, together with its related offerings and services, is widely adopted by hospitals, laboratories, and biopharmaceutical organizations across the globe. Founded in 2011, SOPHiA GENETICS S.A. is headquartered in Saint-Sulpice, Switzerland.